Cargando…
Modelling in Synthesis and Optimization of Active Vaccinal Components
Cancer is the second leading cause of mortality worldwide, behind heart diseases, accounting for 10 million deaths each year. This study focusses on adenocarcinoma, which is a target of a number of anticancer therapies presently being tested in medical and pharmaceutical studies. The innovative stud...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625944/ https://www.ncbi.nlm.nih.gov/pubmed/34835765 http://dx.doi.org/10.3390/nano11113001 |
_version_ | 1784606545508564992 |
---|---|
author | Margin, Oana-Constantina Dulf, Eva-Henrietta Mocan, Teodora Mocan, Lucian |
author_facet | Margin, Oana-Constantina Dulf, Eva-Henrietta Mocan, Teodora Mocan, Lucian |
author_sort | Margin, Oana-Constantina |
collection | PubMed |
description | Cancer is the second leading cause of mortality worldwide, behind heart diseases, accounting for 10 million deaths each year. This study focusses on adenocarcinoma, which is a target of a number of anticancer therapies presently being tested in medical and pharmaceutical studies. The innovative study for a therapeutic vaccine comprises the investigation of gold nanoparticles and their influence on the immune response for the annihilation of cancer cells. The model is intended to be realized using Quantitative-Structure Activity Relationship (QSAR) methods, explicitly artificial neural networks combined with fuzzy rules, to enhance automated properties of neural nets with human perception characteristics. Image processing techniques such as morphological transformations and watershed segmentation are used to extract and calculate certain molecular characteristics from hyperspectral images. The quantification of single-cell properties is one of the key resolutions, representing the treatment efficiency in therapy of colon and rectum cancerous conditions. This was accomplished by using manually counted cells as a reference point for comparing segmentation results. The early findings acquired are conclusive for further study; thus, the extracted features will be used in the feature optimization process first, followed by neural network building of the required model. |
format | Online Article Text |
id | pubmed-8625944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86259442021-11-27 Modelling in Synthesis and Optimization of Active Vaccinal Components Margin, Oana-Constantina Dulf, Eva-Henrietta Mocan, Teodora Mocan, Lucian Nanomaterials (Basel) Article Cancer is the second leading cause of mortality worldwide, behind heart diseases, accounting for 10 million deaths each year. This study focusses on adenocarcinoma, which is a target of a number of anticancer therapies presently being tested in medical and pharmaceutical studies. The innovative study for a therapeutic vaccine comprises the investigation of gold nanoparticles and their influence on the immune response for the annihilation of cancer cells. The model is intended to be realized using Quantitative-Structure Activity Relationship (QSAR) methods, explicitly artificial neural networks combined with fuzzy rules, to enhance automated properties of neural nets with human perception characteristics. Image processing techniques such as morphological transformations and watershed segmentation are used to extract and calculate certain molecular characteristics from hyperspectral images. The quantification of single-cell properties is one of the key resolutions, representing the treatment efficiency in therapy of colon and rectum cancerous conditions. This was accomplished by using manually counted cells as a reference point for comparing segmentation results. The early findings acquired are conclusive for further study; thus, the extracted features will be used in the feature optimization process first, followed by neural network building of the required model. MDPI 2021-11-08 /pmc/articles/PMC8625944/ /pubmed/34835765 http://dx.doi.org/10.3390/nano11113001 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Margin, Oana-Constantina Dulf, Eva-Henrietta Mocan, Teodora Mocan, Lucian Modelling in Synthesis and Optimization of Active Vaccinal Components |
title | Modelling in Synthesis and Optimization of Active Vaccinal Components |
title_full | Modelling in Synthesis and Optimization of Active Vaccinal Components |
title_fullStr | Modelling in Synthesis and Optimization of Active Vaccinal Components |
title_full_unstemmed | Modelling in Synthesis and Optimization of Active Vaccinal Components |
title_short | Modelling in Synthesis and Optimization of Active Vaccinal Components |
title_sort | modelling in synthesis and optimization of active vaccinal components |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625944/ https://www.ncbi.nlm.nih.gov/pubmed/34835765 http://dx.doi.org/10.3390/nano11113001 |
work_keys_str_mv | AT marginoanaconstantina modellinginsynthesisandoptimizationofactivevaccinalcomponents AT dulfevahenrietta modellinginsynthesisandoptimizationofactivevaccinalcomponents AT mocanteodora modellinginsynthesisandoptimizationofactivevaccinalcomponents AT mocanlucian modellinginsynthesisandoptimizationofactivevaccinalcomponents |